Heart
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
32310612 2020. Cardiac Manifestations Of Coronavirus (COVID-19)
32281055 ä. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
32360119 ä. COVID-19 myopericarditis: It should be kept in mind in today s conditions
32317203 ä. Cardiovascular complications in COVID-19
32251498 ä. Hypertension and COVID-19
32209811 2020. Angiotensin II for the Treatment of COVID-19?Related Vasodilatory Shock
32303363 ä. ...impact sur le systeme cardiovasculaire...
32344395 2020. The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection
32252591 2020. COVID-19 and the Heart
32363334 ä. Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO)
32371557 2020. SARS-CoV-2 and myocardial injury: Few answers, many questions
32331780 ä. COVID-19-related cardiac involvement and potential implications for cardiothoracic imaging
32318865 2020. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
32247212 2020. Cardiovascular disease and COVID-19
32363381 ä. Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?
32227076 ä. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19
32196087 ä. SARS-CoV2: should inhibitors of the renin?angiotensin system be withdrawn in patients with COVID-19?
32267502 ä. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection
32267494 ä. CAPACITY-COVID: a European registry to determine the role of cardiovascular disease in the COVID-19 pandemic
32285920 ä. Transient complete heart block in a patient with critical COVID-19
32285915 ä. Typical takotsubo syndrome triggered by SARS-CoV-2 infection
32338706 ä. Myocarditis revealing COVID-19 infection in a young patient
32282027 ä. COVID-19-related myocarditis in a 21-year-old female patient
32359887 ä. SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade
32354800 2020. Cardiovascular manifestations and treatment considerations in covid-19
32305329 2020. Cardiovascular and Logistic Issues Associated With COVID-19 Pandemic
32373465 ä. Syncope as the presenting symptom of COVID-19 infection
32315757 ä. Current data on the cardiovascular effects of the COVID-19
32140732 ä. SARS-CoV-2: a potential novel etiology of fulminant myocarditis
32333026 ä. Arrhythmias and sudden cardiac death in the COVID-19 pandemic
32322935 ä. SARS-CoV-2 as potential cause of cardiac inflammation and heart failure Is it the virus, hyperinflammation, or MODS?
32355222 ä. A novel COVID-19 and its effects on cardiovascular disease
32277408 ä. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights
32360773 ä. May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?
32276773 ä. Commentary: What is the relationship between Covid-19 and cardiovascular disease?
32291207 ä. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China?
32276774 ä. SARS-CoV-2 inflames the heart The importance of awareness of myocardial injury in COVID-19 patients
32299753 ä. Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society
32209382 ä. The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease
32370558 2020. Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection
32360703 ä. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications
32339565 ä. COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
32289321 ä. Cardiovascular molecular mechanisms of disease with COVID-19
C7151324 ä. The Heart in COVID19: Primary Target or Secondary Bystander?
32368756 ä. HEART BRAKE-An unusual cardiac manifestation of Coronavirus disease 2019 (COVID-19)
32368755 ä. A Recovered Case of COVID-19 Myocarditis and ARDS Treated with Corticosteroids, Tocilizumab, and Experimental AT-001
32363351 ä. Takotsubo Syndrome in the Setting of COVID-19 Infection
32342050 ä. COVID-19 STEMI 2020: It?s Not What You Know, It?s How You Think
32342049 ä. Pseudo acute myocardial infarction in a young COVID-19 patient
32328588 ä. Cardiac Tamponade Secondary to COVID-19
32310242 ä. The Known into the Unknown: Brugada syndrome and COVID-19
32309815 ä. Transient Brugada-like ECG pattern in a patient with Coronavirus Disease 2019 (COVID-19)
32265149 ä. End-stage Heart Failure with COVID-19: Strong Evidence of Myocardial Injury by 2019-nCoV
32360242 2020. COVID-19 Illness and Heart Failure: A Missing Link?
32211816 ä. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
32334650 ä. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes
32360126 2020. Myocardial injury and COVID-19: Possible mechanisms
32302081 ä. ST-Segment Elevation in Patients with Covid-19 ? A Case Series
32319272 2020. COVID-19 and cardiovascular disorder
32340429 2020. The role of natriuretic peptide estimation in severe COVID-19
32348640 ä. Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy
32139904 ä. COVID-19 and the cardiovascular system
32329981 2020. Terra incognita: clinically suspected myocarditis in a SARS-CoV-2 positive patient
32169400 ä. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis?
32353374 ä. Towards precision management of cardiovascular patients with COVID-19 to reduce mortality
32305557 ä. The impact of 2019 novel coronavirus on heart injury: A systemic review and Meta-analysis
32293449 2020. Prognostic value of NT-proBNP in patients with severe COVID-19
32372844 ä. COVID-19 y tratamiento guiado con tests de diagn�stico bioqu�micos y moleculares para reducir el da�o cardiaco y la cardiotoxicidad
32355394 ä. COVID-19 y shock cardiog�nico: diferentes formas de presentaci�n cardiovascular con alta mortalidad
32345547 ä. Fulminant myocarditis due to COVID-19
32267110 2020. COVID-19 et maladies cardiovasculaires
32227794 2020. At the heart of the COVID-19 outbreak: early cardiac implications and mitigating strategies
32312365 2020. Research advances in cardiovascular system damage caused by SARS-CoV-2 in children
